Exhibit 12.1
Gilead Sciences, Inc.
Computation of Ratio of Earnings to Fixed Charges
(In millions, except ratios)
|
| Six Months |
|
|
|
|
|
|
|
|
|
|
| ||||||
|
| Ended June 30, |
| Year Ended December 31, |
| ||||||||||||||
|
| 2017 |
| 2016 |
| 2015 |
| 2014 |
| 2013 |
| 2012 |
| ||||||
Earnings: |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Income before provision for income taxes |
| $ | 7,732 |
| $ | 17,097 |
| $ | 21,659 |
| $ | 14,856 |
| $ | 4,208 |
| $ | 3,612 |
|
Interest expense |
| $ | 530 |
| $ | 964 |
| $ | 688 |
| $ | 412 |
| $ | 307 |
| $ | 361 |
|
Interest portion of operating lease expense |
| $ | 11 |
| $ | 20 |
| $ | 19 |
| $ | 16 |
| $ | 13 |
| $ | 13 |
|
Net loss attributable to non-controlling interest |
| $ | 7 |
| $ | 13 |
| $ | 2 |
| $ | 42 |
| $ | 18 |
| $ | 18 |
|
Total Earnings |
| $ | 8,280 |
| $ | 18,094 |
| $ | 22,368 |
| $ | 15,326 |
| $ | 4,546 |
| $ | 4,004 |
|
Fixed Charges: |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Interest expense |
| $ | 530 |
| $ | 964 |
| $ | 688 |
| $ | 412 |
| $ | 307 |
| $ | 361 |
|
Capitalized interest |
| $ | 9 |
| $ | 17 |
| $ | 12 |
| $ | 3 |
| $ | 2 |
| $ | 6 |
|
Interest portion of operating lease expense |
| $ | 11 |
| $ | 20 |
| $ | 19 |
| $ | 16 |
| $ | 13 |
| $ | 13 |
|
Total Fixed Charges |
| $ | 550 |
| $ | 1,001 |
| $ | 719 |
| $ | 432 |
| $ | 323 |
| $ | 380 |
|
Ratio of Earnings to Fixed Charges |
| 15.1 |
| 18.1 |
| 31.1 |
| 35.5 |
| 14.1 |
| 10.5 |
| ||||||
